Our Vision
The Alliance for Clinical Trials in Oncology seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer.
Our Mission
The mission of the Alliance for Clinical Trials in Oncology is to reduce the impact of cancer by:
- Conducting high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network
- Furthering our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice
- Providing a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings
What We do
The Alliance for Clinical Trials in Oncology develops and conducts clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as research methods to alleviate side effects of cancer and cancer treatments. The Alliance is part of the National Clinical Trials Network (NCTN) sponsored by the National Cancer Institute (NCI) and serves as a research base for the NCI Community Research Oncology Program (NCORP). The Alliance comprises nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. Learn more about collaborating with the Alliance here.
